Search - tctmd.com

Displaying 721 - 740 of 1431

Sort: Relevancy | Date

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Conference News SCCT 2019

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Yael L. Maxwell

July 12, 2019

News Daily News

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

L.A. McKeown

July 02, 2019

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Daily News

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

Yael L. Maxwell

June 20, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News ESC Heart Failure 2019

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

Advertisement

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

Hemodynamics: The Forgotten Branch of Cardiology

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content